In the first part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, defines the term, and explains how ...

In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven ...

A systematic review determines if adult patients with language barriers are less likely to use the video-based virtual care ...

In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional ...

An Applied Clinical Trials article explores the complex and often conflicting perspectives of sponsors, CROs, and research sites on fair market value in clinical trial budgeting, emphasizing the need ...

In the second part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, details what the company’s ...

Marketed as BNT327, the PD-L1xVEGF-A bispecific antibody has the potential to become what the involved parties believe is a ...

Ron Lanton, Partner, Lanton Law, weighs in on the potential international trade, pricing, and access implications of tying US drug costs to those in other developed countries under the Most Favored ...

In the third part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, comments on how mobile and digital solutions can be deployed effectively to close the gap in areas ...

In an interview with Applied Clinical Trials, Jim Kremidas, executive director of the Association for MultiSite Research Corporations, discussed how partnering with multisite clinical research ...

In an effort to greater prepare HCPs and to avoid potential shortages, the company targets Q3 as the shipment date. Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV ...